Presenting and exhibiting at ISPOR US

Adelphi Values will be presenting and exhibiting at the 22nd Annual International Meeting of ISPOR, the International Society of Pharmacoeconomics and Outcomes Research, which takes place from 20th‑24th May 2017 in Boston, MA, USA.

Team members from Adelphi Values | PROVE, Patient-Centered Outcomes and our sister company Adelphi Real World will be on hand at booths 612/614 to discuss the wide range of tailored Real World, Value and Outcomes solutions we offer to overcome the challenges of developing and commercialising healthcare products and services.

In addition, team members from both our UK and US offices will be presenting a workshop and a forum as well as a wide range of posters across a variety of therapy areas and topics including oncology, rare genetic diseases, ophthalmology and endocrinology.

The workshop is entitled ‘Conducting qualitative ‘exit’ interviews following clinical trials or observational studies: a valuable method for understanding the patient experience, informing measurement strategy, and aiding interpretation of patient-reported outcomes’.  This workshop will be co-presented by Rob Arbuckle, Managing Director, Patient-Centered Outcomes UK, on Wednesday 24th May at 8:45am in Sheraton-Back Bay CD – 2nd floor. Through the use of examples from a range of disease areas, this workshop will stimulate discussion regarding the value generated by ‘exit’ interview data and ways to overcome common challenges and limitations.

The forum presentation is entitled ‘How does measurement of multiple medication adherence differ between chronic diseases?’ and will be presented on Monday 22nd May at 6:15pm by the ISPOR Medication Adherence Special Interest Group, with Bryan Bennett, Director, Patient-Centered Outcomes UK, as one of the three speakers.  This interactive forum will look at the most common methods used to calculate adherence to multiple medications (AtMM), an assessment of the studies carried out, and the need to evaluate the differences between diseases in evaluating and deriving multiple adherence as well as determining the implications of using different measurements.  Participants will be encouraged to contribute their experience and will have the opportunity to discuss and suggest potential solutions to the issues.

With thousands of attendees from around 80 countries, ISPOR is recognised as the leading scientific and educational organisation for outcomes research in healthcare decisions and hosts many of the foremost experts around the world.  This year’s event is entitled ‘Evidence and Value in a Time of Social and Policy Change’  and provides a great platform for knowledge sharing.

If you would like further information on our presentations at ISPOR or on any of our broader PROVE or Patient-Centered Outcomes solutions, please contact us or alternatively come and speak to a member of our team at booths 612/614 – we look forward to seeing you!